OA09658A - Materials and methods for the treatment of foreign tissue - Google Patents

Materials and methods for the treatment of foreign tissue

Info

Publication number
OA09658A
OA09658A OA60192A OA60192A OA09658A OA 09658 A OA09658 A OA 09658A OA 60192 A OA60192 A OA 60192A OA 60192 A OA60192 A OA 60192A OA 09658 A OA09658 A OA 09658A
Authority
OA
OAPI
Prior art keywords
treatment
materials
methods
foreign tissue
foreign
Prior art date
Application number
OA60192A
Inventor
Herman Waldman
Kenneth Ian Welsh
Michael Gordon Thick
David Hirsch Taube
Geoffrey Hale
Original Assignee
Lynxvale Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898923712A external-priority patent/GB8923712D0/en
Application filed by Lynxvale Ltd filed Critical Lynxvale Ltd
Publication of OA09658A publication Critical patent/OA09658A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/289—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
OA60192A 1989-10-20 1992-04-20 Materials and methods for the treatment of foreign tissue OA09658A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42474889A 1989-10-20 1989-10-20
GB898923712A GB8923712D0 (en) 1989-10-20 1989-10-20 Compounds and methods for the amelioration of graft rejection

Publications (1)

Publication Number Publication Date
OA09658A true OA09658A (en) 1993-05-15

Family

ID=26296086

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60192A OA09658A (en) 1989-10-20 1992-04-20 Materials and methods for the treatment of foreign tissue

Country Status (8)

Country Link
EP (1) EP0496806A1 (en)
JP (1) JPH05501256A (en)
AU (1) AU631272B2 (en)
BR (1) BR9007769A (en)
CA (1) CA2069342A1 (en)
FI (1) FI921746A0 (en)
OA (1) OA09658A (en)
WO (1) WO1991005568A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595911A (en) * 1990-03-14 1997-01-21 Cold Spring Harbor Laboratory Isolation of a cDNA encoding a protein tyrosine phosphatase which localizes to focal adhesions
US6197298B1 (en) 1991-04-19 2001-03-06 Tanox, Inc. Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
CA2065658A1 (en) * 1991-04-19 1992-10-20 Tse-Wen Chang Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
US6106835A (en) * 1991-04-19 2000-08-22 Tanox, Inc. Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
US6129916A (en) * 1991-04-19 2000-10-10 Tanox, Inc. Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
US5872222A (en) * 1991-04-19 1999-02-16 Tanox Biosystems, Inc. Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants
WO1993007900A1 (en) * 1991-10-18 1993-04-29 Cantab Pharmaceuticals Research Limited In vitro antibody perfusion of kidney grafts
US6106834A (en) * 1993-06-02 2000-08-22 Research Corporation Technologies, Inc. Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
US6024957A (en) * 1993-06-02 2000-02-15 Research Corporation Technologies, Inc. Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
CA2164717C (en) * 1993-06-10 2009-10-20 Louis S. Kucera Method of combatting hepatitis b virus infection
GB201412658D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
GB201601073D0 (en) * 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies
GB201601077D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibody molecule
GB201521382D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521389D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Method
JP2023547795A (en) * 2020-10-15 2023-11-14 ユーシービー バイオファルマ エスアールエル Binding molecules that multimerize CD45

Also Published As

Publication number Publication date
FI921746L (en) 1992-04-16
WO1991005568A1 (en) 1991-05-02
FI921746A7 (en) 1992-04-16
FI921746A0 (en) 1992-04-16
EP0496806A1 (en) 1992-08-05
AU631272B2 (en) 1992-11-19
BR9007769A (en) 1992-08-11
CA2069342A1 (en) 1991-04-21
AU6623590A (en) 1991-05-16
JPH05501256A (en) 1993-03-11

Similar Documents

Publication Publication Date Title
SG49658A1 (en) Treatment of condition and disease
HU894789D0 (en) Process for the production of replantable tissue material and for its use
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
IL96915A0 (en) Method and apparatus for fragmentation of hard substances within the human body
OA09658A (en) Materials and methods for the treatment of foreign tissue
EP0506893A4 (en) Diagnosis and treatment of diseases
GB9111216D0 (en) Tissue dispenser and method of making the same
EP0453497A4 (en) Treatment methods and vaccines
GB9201848D0 (en) Treatment of fibrous materials
IL92299A0 (en) Process and device for the treatment of cotton
EP0427427A3 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
EP0436717A4 (en) Method of treatment with medical agents
GB2233898B (en) Agent for preventing and treating opacity of the lens
GB8922675D0 (en) Apparatus and methods of sterilization
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
EP0427942A3 (en) Process for the preparation of s-triazine-sulfenimides and their use
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
EP0407016A3 (en) Use of benzodioxinopyrrole derivatives in the treatment of anxiety
IL94270A0 (en) Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
GB8903284D0 (en) Treatment of materials
HU902615D0 (en) Process and apparatus for the determination of haemodynamical characteristics of human heart
HRP931137A2 (en) Process for the preparation of human stephine b and the mutants thereof
GB8907372D0 (en) Cleansing of the human body
IE893145L (en) Compounds and methods for the treatment and diagnosis of¹cancer
SU1568986A1 (en) Method of surgical treating of prognathia and marcognathia